• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Select Pharmaceuticals Portfolio

+ Add to Watchlist

FPHAX:US

21.65 USD 0.21 0.98%

As of 09:29:30 ET on 09/16/2014.

Snapshot for Fidelity Select Pharmaceuticals Portfolio (FPHAX)

Year To Date: +19.15% 3-Month: +6.60% 3-Year: +27.66% 52-Week Range: 16.05 - 21.65
1-Month: +6.23% 1-Year: +34.11% 5-Year: +22.88% Beta vs MXWO: 0.89

Mutual Fund Chart for FPHAX

No chart data available.
  • FPHAX:US 21.65
  • 1M
  • 1Y
Interactive FPHAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FPHAX

Fidelity Select Pharmaceuticals Portfolio is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types.

Inception Date: 06-18-2001 Telephone: 1-800-544-6666
Managers: ASHER ANOLIC
Web Site: www.fidelity.com

Fundamentals for FPHAX

NAV (on 2014-09-16) 21.65
Assets (M) (on 2014-08-29) 1,539.96
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FPHAX

Dividend Type Short Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-04-11) 0.35
Dividend Yield (ttm) 12.64

Fees & Expenses for FPHAX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 0.00
Expense Ratio 0.81

Top Fund Holdings for FPHAX

Filing Date: 07/31/2014
Name Position Value % of Total
Actavis plc 601,507 128,878,890 8.494%
AbbVie Inc 2,006,690 105,030,155 6.922%
AstraZeneca PLC 1,129,500 82,216,305 5.419%
Johnson & Johnson 793,000 79,371,370 5.231%
Novartis AG 912,098 79,297,800 5.226%
Bristol-Myers Squibb Co 1,499,810 75,920,382 5.004%
Shire PLC 280,800 69,217,200 4.562%
Merck & Co Inc 1,183,236 67,136,811 4.425%
Perrigo Co PLC 422,452 63,557,903 4.189%
Novo Nordisk A/S 1,202,200 55,361,310 3.649%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil